New study to track anthrax drug in rare outbreaks
NCT ID NCT03569514
First seen Feb 06, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study looks at how safe and helpful an anthrax treatment called AIGIV is for people with a serious form of anthrax infection. Researchers will follow up to 10 patients who receive AIGIV during an outbreak to see if it reduces deaths and causes any side effects. The goal is to learn more about how well the treatment works in real-world cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.